Is Catalyst Pharmaceuticals, Inc. overvalued?

Catalyst Pharmaceuticals, Inc. (CPRX) looks undervalued — trading about 33% below its fair value.

Undervalued

Price

$31.49

Fair value

$41.94

Current P/E

11.3

Normal P/E

15.1

Market cap

$3.85B

Dividend yield

0.0%

Return on equity

23.7%

Sector

Healthcare

Fair value compares CPRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks